This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
TE Adrian , GH Ballantyne , WE Longo , AJ Bilchik , S Graham , MD Basson , RP Tierney & IM Modlin (1993) Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut 34, 1219–1224.
TE Adrian , GL Ferri , AJ Bacarese-Hamilton , HS Fuessl , JM Polak & SR Bloom (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070–1077.
TE Adrian , AP Savage , AJ Bacarese-Hamilton , K Wolfe , HS Besterman & SR Bloom (1986) Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90, 379–384.
TE Adrian , AP Savage , GR Sagor , JM Allen , AJ Bacarese-Hamilton , K Tatemoto , JM Polak & SR Bloom (1985) Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89, 494–499.
Y Anini , X Fu-Cheng , JC Cuber , A Kervran , J Chariot & C Roz (1999) Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Archiv 438, 299–306.
RL Batterham , MA Cohen , SM Ellis , CW Le Roux , DJ Withers , GS Frost , MA Ghatei & SR Bloom (2003) Inhibition of food intake in obese subjects by peptide YY3–36. New England Journal of Medicine 349, 941–948.
RL Batterham , MA Cowley , CJ Small , H Herzog , MA Cohen & CL Dakin . (2002) Gut hormone PYY (3–36) physiologically inhibits food intake. Nature 418, 650–654.
B Bonaz , I Taylor & Y Tache (1993) Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain. Neuroscience Letters 163, 77–80.
BG Challis , AP Coll , GS Yeo , SB Pinnock , SL Dickson & RR Thresher . (2004) Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY3–36. Proceedings of the National Academy of Sciences USA 101, 4695–4700.
BG Challis , SB Pinnock , AP Coll , RN Carter , SL Dickson , S O'Rahilly (2003) Acute effects of PYY3–36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochemical and Biophysical Research Communications 311, 915–919.
MA Cowley , JL Smart , M Rubinstein , MG Cerdan , S Diano , TL Horvath , RD Cone & MJ Low (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484.
MA Cowley , RG Smith , S Diano , M Tschop , N Pronchuk & KL Grove . (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649–661.
JE Cox & A Randich (2004) Enhancement of feeding suppression by PYY(3–36) in rats with area postrema ablations. Peptides 25, 985–989.
S Delgado-Aros , F Cremonini , JE Castillo , HJ Chial , DD Burton , I Ferber & M Camilleri (2004) Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 126, 432–440.
Y Dumont , A Fournier , S St-Pierre & R Quirion (1996) Autoradiographic distribution of [125I]Leu31, Pro34]PYY and [125I]PYY3–36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22, 139–158.
GA Eberlein , VE Eysselein , M Schaeffer , P Layer , D Grandt , H Goebell , W Niebel , M Davis , TD Lee & JE Shively (1989) A new molecular form of PYY: structural characterization of human PYY(3–36) and PYY(1–36). Peptides 10, 797–803.
N Finer (2003) Obesity. Clinical Medicine 3, 23–27.
KM Flegal , MD Carroll , CL Ogden & CL Johnson (2002) Prevalence and trends in obesity among US adults, 1999–2000. Journal of the American Medical Association 288, 1723–1727.
PJ Geiselman (1996) Control of food intake. A physiologically complex, motivated behavioral system. Endocrinology and Metabolism Clinics of North America 25, 815–829.
J Gibbs , RC Young & GP Smith (1973) Cholecystokinin decreases food intake in rats. Journal of Comparative Physiology and Psychology 84, 488–495.
D Grandt , M Schimiczek , C Beglinger , P Layer , H Goebell , VE Eysselein , JR Reeve Jr (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36. Regulatory Peptides 51, 151–159.
MM Hagan (2002) Peptide YY: a key mediator of orexigenic behavior. Peptides 23, 377–382.
IG Halatchev , KL Ellacott , W Fan & RD Cone (2004) Peptide YY3–36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145, 2585–2590.
JO Hill , HR Wyatt , GW Reed & JC Peters (2003) Obesity and the environment: where do we go from here. Science 299, 853–855.
M Imamura (2002) Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides 23, 403–407.
A Kervran , P Blache & D Bataille (1987) Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology 121, 704–713.
AL Kirchgessner & M Liu (1999) Orexin synthesis and response in the gut. Neuron 24, 941–951.
RA Leslie , TJ McDonald & HA Robertson (1988) Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata. Peptides 9, 1071–1076.
HC Lin & WY Chey (2003) Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regulatory Peptides 114, 131–135.
HC Lin , WY Chey & X Zhao (2000) Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK. Peptides 21, 1561–1563.
I Merchenthaler (1991) Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold. Neuroscience 44, 655–662.
N Nonaka , S Shioda , ML Niehoff & WA Banks (2003) Characterization of blood-brain barrier permeability to PYY3–36 in the mouse. Journal of Pharmacology and Experimental Therapuetics 306, 948–953.
U Pedersen-Bjergaard , U Host , H Kelbaek , S Schifter , JF Rehfeld , J Faber & NJ Christensen (1996) Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scandinavian Journal of Clinical and Laboratory Investigation 56, 497–503.
RA Pittner , CX Moore , SP Bhavsar , BR Gedulin , PA Smith , CM Jodka , DG Parkes , JR Paterniti , VP Srivastava & AA Young (2004) Effects of PYY[3–36] in rodent models of diabetes and obesity. International Journal of Obesity and Related Metabolic Disorders 28, 963–971.
EK Potter , JA Barden , MJ McCloskey , LA Selbie , A Tseng , H Herzog & J Shine (1994) A novel neuropeptide Y analog, N-acetyl [Leu28, Leu31]neuropeptide Y-(24–36), with functional specificity for the presynaptic (Y2) receptor. European Journal of Pharmacology 267, 253–262.
T Riediger , C Bothe , C Becskei & TA Lutz (2004) Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-fos expression. Neuroendocrinology 79, 317–326.
M Rosenbaum , RL Leibel & J Hirsch (1997) Obesity. New England Journal of Medicine 337, 396–407.
M Tang-Christensen , PJ Larsen , J Thulesen , J Romer & N Vrang (2000) The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nature Medicine 6, 802–807.
M Tschop , TR Castaneda , HG Joost , C Thone-Reineke , S Ortmann & S Klaus . (2004) Physiology: does gut hormone PYY3–36 decrease food intake in rodents. Nature 430, 165–167.
AM Wren , CJ Small , CR Abbott , WS Dhillo , LJ Seal , MA Cohen , RL Batterham , S Taheri , SA Stanley , MA Ghatei & SR Bloom (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547.